Sign inJoin waitlistJoin the waitlist

Gregory Vlacich

Vice Chair of Clinical Operations · Washington University/B-JH/SLCH Consortium

Credentials: · · · · · · ·

History

Washington University/B-JH/SLCH Consortium
Present
Washington University/B-JH/SLCH Consortium
Present
Alvin J. Siteman Cancer Center
Present

Radiation Oncology
Vanderbilt University Medical Center
2010–2014
St. Vincent's Catholic Medical Center
2009–2010
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
2005–2009
University of Chicago, Pritzker School of Medicine
2007
Yale University, New Haven, CT
1995–1999

Research

Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database
Cancer Medicine · 2017 · First of 11 authors · Corresponding · 54 citations
Lrig1+ gastric isthmal progenitor cells restore normal gastric lineage cells during damage recovery in adult mouse stomach
Gut · 2018 · 54 citations
Inducible loss of one Apc allele in Lrig1-expressing progenitor cells results in multiple distal colonic tumors with features of familial adenomatous polyposis
American Journal of Physiology-Gastrointestinal and Liver Physiology · 2014 · 52 citations

Clifford Robinson
10 papers
Pamela Samson
10 papers · 4 as a resident
Shahed Badiyan
6 papers
Aadel Chaudhuri
4 papers · 4 as a resident
Anthony Cmelak
3 papers
Eric Laugeman
3 papers
Joshua Schiff
3 papers · 2 as a resident
Nick Semenkovich
3 papers · 2 as a fellow
Ramaswamy Govindan
3 papers
Robert Coffey
3 papers
Saima Waqar
3 papers
Carmen Bergom
2 papers

Clinical trials

Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer
Principal investigator · Active not recruiting · Phase 1
Washington University School of Medicine
2019–2029
Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer
Principal investigator · Completed · Phase 2
Washington University School of Medicine
2019–2025
Proton Beam Therapy in the Treatment of Esophageal Cancer
Principal investigator · Active not recruiting
Washington University School of Medicine
2018–2026
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Sub-investigator · Not yet recruiting · Phase 1, Phase 2
Washington University School of Medicine
2026–2033